1. Home
  2. Labeler Index
  3. Aurohealth Llc
  4. 58602-817
  5. NDC Package Code: 58602-817-90 Acetaminophen Aspirin And Caffeine

NDC Package 58602-817-90 Acetaminophen Aspirin And Caffeine

Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
58602-817-90
Package Description:
1 BOTTLE in 1 CARTON / 125 TABLET, FILM COATED in 1 BOTTLE
Product Code:
58602-817
Proprietary Name:
Acetaminophen Aspirin And Caffeine
Non-Proprietary Name:
Acetaminophen, Aspirin And Caffeine
Substance Name:
Acetaminophen; Aspirin; Caffeine
Usage Information:
Do not use more than directedadults: take 2 tablets with a glass of waterif symptoms persist or worsen, ask your doctordo not take more than 2 tablets in 24 hours, unless directed by a doctorunder 18 years of age: ask a doctor
11-Digit NDC Billing Format:
58602081790
NDC to RxNorm Crosswalk:
  • RxCUI: 308297 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet
  • RxCUI: 308297 - APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet
    • Product Type:
    Human Otc Drug
    Labeler Name:
    Aurohealth Llc
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ACETAMINOPHEN 250 mg/1
  • ASPIRIN 250 mg/1
  • CAFFEINE 65 mg/1
    • Pharmacologic Class(es):
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
  • Central Nervous System Stimulation - [PE] (Physiologic Effect)
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Decreased Platelet Aggregation - [PE] (Physiologic Effect)
  • Decreased Prostaglandin Production - [PE] (Physiologic Effect)
  • Methylxanthine - [EPC] (Established Pharmacologic Class)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
  • Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
  • Xanthines - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA211695
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    02-02-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    58602-817-021 BOTTLE in 1 CARTON / 8 TABLET, FILM COATED in 1 BOTTLE
    58602-817-031 BOTTLE in 1 CARTON / 10 TABLET, FILM COATED in 1 BOTTLE
    58602-817-071 BOTTLE in 1 CARTON / 24 TABLET, FILM COATED in 1 BOTTLE
    58602-817-091 BOTTLE in 1 CARTON / 30 TABLET, FILM COATED in 1 BOTTLE
    58602-817-141 BOTTLE in 1 CARTON / 50 TABLET, FILM COATED in 1 BOTTLE
    58602-817-211 BOTTLE in 1 CARTON / 100 TABLET, FILM COATED in 1 BOTTLE
    58602-817-34200 TABLET, FILM COATED in 1 BOTTLE
    58602-817-36250 TABLET, FILM COATED in 1 BOTTLE
    58602-817-38300 TABLET, FILM COATED in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 58602-817-90?

    The NDC Packaged Code 58602-817-90 is assigned to a package of 1 bottle in 1 carton / 125 tablet, film coated in 1 bottle of Acetaminophen Aspirin And Caffeine, a human over the counter drug labeled by Aurohealth Llc. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 58602-817 included in the NDC Directory?

    Yes, Acetaminophen Aspirin And Caffeine with product code 58602-817 is active and included in the NDC Directory. The product was first marketed by Aurohealth Llc on February 02, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 58602-817-90?

    The 11-digit format is 58602081790. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-258602-817-905-4-258602-0817-90